Mr Ashley Woodcock

Professor of General Medicine


Clinical Interests

  • Respiratory Medicine
  • Cough
  • Asthma

Professional Memberships

  • FRCP
  • FERS
  • FMedSci


Personal profile

1969-75: University of Manchester (Intercalated BSc 1972)
1975-1977: HO/SHO Withington Hospital, Manchester Royal infirmary, Hammersmith Hospital, Royal Brompton Hospital
1977-79: Physician; Bandar Seri Begawan, Brunei
1979-85: Research Fellow/Senior Registrar; St James Balham and Royal Brompton Hospitals

1972: BSc (Physiology) First Class Hons, University of Manchester
1975: MB ChB (Hons) Distinctions in Medicine, Psychiatry and Paediatrics
1977: MRCP (London)
1982: MD University of Manchester
1992: FRCP (Royal College of Physicians, London)
2014: Fellowship of the European Respiratory Society
2008: Fellowship of the Academy of Medical Sciences
2018:  Fellowship College of Pharmaceutical Physicians

2006: OBE (Services to the Environment)
2007: Contributed to Nobel Peace Prize with IPCC/Al Gore

Clinical Appointments:
1988: Consultant Physician, North West Lung Centre (since 2011), Wythenshawe Hospital, Manchester University Foundation Trust
1998: Professor of Respiratory Medicine, Associate Dean for Clinical Affairs (since 2016), University of Manchester

Other positions held:
Montreal Protocol for the Protection of the Ozone Layer, United Nations Environment Programme
1995-2014: Co-chair Medical Technical Options Committee 
2015-continuing: Co-Chair: Technology and Economic Assessment Panel, Montreal Protocol 
2017-2020: Co-Chair: Energy Efficiency Task Force; Member Replenishment Task Force

Royal College of Physicians:
Secretary:  Royal College of Physicians Report: "Smoking and the Young", 1992
Lead:  Royal College of Physicians "Children's Charter, Freedom from Tobacco" 1992
Member: Royal College of Physicians Tobacco Advisory Group 2002-2005
Council Member: 2016 - 2019

British Thoracic Society: 
President: 2013-2014
Chair: Public Relations Committee/Member of Executive 1988-1992; 
Member Council 2001-2004 

National Institute of Health Research
Director: NIHR Respiratory and Allergy Clinical Research Facility: 2011-2015
NIHR Senior Investigator 2011–2018;  Emeritus 2019 - current

Research Roles
Chairman: Asthma UK Early Life Task Force: 2002-2005
Founder:  MRC STELAR collaboration of all UK infant asthma cohorts
Chairman: Trials Steering Committee: UK Cystic Fibrosis Gene Therapy Trial 2014-2016
Chief Investigator: Salford Lung Study of clinical effectiveness in asthma and COPD (GSK sponsored ~£60million inward investment into NW research infrastructure): 2011-2017

NW Lung Centre Charity; Board Member: contributed £5million to lung research in last 10 years
Moulton Charity:  Science Director; provided £47million in the last 10 years, for clinical trials designed to provide patient benefit within 2-3 years


Year qualified: